To evaluate the hepatic metabolic alterations in nonalcoholic fatty liver disease (NAFLD) by using 1H‐MRS (proton magnetic resonance spectroscopy) with long echo time and to test the reproducibility of human… Click to show full abstract
To evaluate the hepatic metabolic alterations in nonalcoholic fatty liver disease (NAFLD) by using 1H‐MRS (proton magnetic resonance spectroscopy) with long echo time and to test the reproducibility of human study in an animal model. Liver biopsy is the gold standard for diagnosing NAFLD but with practical constraints. 1H‐MRS allows in vivo assessment of hepatocellular metabolism and has shown potential for biochemical differentiation in diffuse liver disease.
               
Click one of the above tabs to view related content.